All analyses
AI analysis

HNB Life PLC: research report

Moderately undervaluedbullishNov 11, 2026

Evidence points positive because nine-month premiums grew 41% while the shares screen moderately undervalued across the market. The catch is that September-quarter profit fell 36%.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • Gross written premiums reported on 10 November rose 41% year-on-year to LKR 19.4 billion for the nine months to September, supporting growth in the insurer's core business.
  • The audited year to December 2025 delivered 25.7% net-profit growth and a 16.9% return on equity, showing that the prior earnings base was profitable.
  • The market-wide valuation score is 74 out of 100, supported by earnings and dividend measures rather than book value alone.

Against this. September-quarter net profit fell 35.9% to LKR 178 million despite 23.9% revenue growth, and its 1.6% net margin was the worst of seven comparable September quarters.

Net margin
1.6%sector 1.4%
from 3.2% a year earlier, revenue +23.9%
Return on equity
17.8%
twelve months to Sep 30, 2026, unaudited
P/E
8.7sector 15.6
earnings Rs 15.73 per share, year to Sep 2026
P/B
1.54sector 1.46
book Rs 88.20 per share
Dividend yield
3.67%sector 1.83%
31.8% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 11, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

HNB Life operates life and general insurance businesses in Sri Lanka through agency, bancassurance and alternate distribution channels. The core premium base expanded strongly through the first nine months of 2026, but the latest standalone quarter shows that translating that growth into profit has become harder.

Price performance

At LKR 140 on 11 November 2026, the share was down 7.3% over three months while the ASPI gained 2.9%, so the recent relative return has lagged the wider market. It stood 75.9% of the way from its 52-week low to high, despite being 8.3% below the high.

The record since November 2023 contains three falls of 15% or more, the deepest 23%, which took six months to recover. Trading is thin: a LKR 1 million order is more than everything that trades on a typical day, 157% of it, making a position of that size a large part of a normal session.

Valuation

The P/E of 8.81 means the market price is LKR 8.81 for every LKR 1 of trailing profit, and it sits at the 25th percentile among the nine insurance peers with usable P/E data. The P/B of 1.59 means LKR 1.59 is paid for each LKR 1 of net assets; the 2025 return on equity was 16.9%, providing an earnings basis for trading above book value.

Against its own record, the P/E is more expensive than 86% of days since January 2019 and P/B is more expensive than 94% of days since January 2019. Thus, the shares are inexpensive beside sector earnings multiples but near the expensive end of their own trading history.

The 3.6% dividend yield is backed by a LKR 5.00 FY2025 payout, up from LKR 3.90 in each of FY2024 and FY2023. A buyer at the current price is relying little on the latest quarter for trailing profit, as it contributed 7.6% of TTM EPS; however, its net margin of 1.6% was below 3.1% a year earlier, and the same price would equate to 8.2 times earnings at the year-ago margin rather than 8.8 times.

News and sentiment

Direct coverage was normal, with two material articles in the past 90 days and both positive. On 10 November, the company reported nine-month gross written premiums of LKR 19.4 billion, net income of LKR 24.9 billion and profit after tax of LKR 602.3 million for the period to 30 September.

Earlier reporting on 7 August described first-half profit after tax of LKR 434 million alongside 43% life gross-written-premium growth. Board and executive appointments at the general-insurance subsidiary were also reported, but their financial effect was not quantified.

Financials

The latest filed September quarter recorded revenue of LKR 10.9 billion, up 23.9% year-on-year, but net profit fell 35.9% to LKR 178 million. In everyday terms, the business brought in more revenue but retained less profit from it.

Net margin narrowed from 3.1% to 1.6%, the worst of seven comparable September quarters. Gross and operating margins are unavailable for both the latest September quarter and its year-ago comparator in the supplied filings, so no like-for-like margin comparison can be made for those measures. Equity rose to LKR 13.2 billion from LKR 12.9 billion a year earlier, while the share count remained 150 million, so the weaker quarterly EPS was not caused by a change in ordinary shares.

The audited year to December 2025 remains the latest full-year filing, with revenue growth of 26.9% and net-profit growth of 25.7%. The 10 November news report gives a newer cumulative nine-month result for the same September end-date, reporting LKR 602.3 million profit after tax; it should be read as reported and not mixed into the filed quarterly margin series.

Risks

The principal risk is profit conversion: September-quarter revenue rose 23.9% but profit fell 35.9%, leaving a 1.6% net margin. The latest quarter was the weakest of seven comparable September periods on that measure, so the earnings behind the current P/E depend on restoring profitability rather than premium growth alone.

As an insurer, liabilities relative to equity rose to 4.71 times at December 2025 from 3.99 times a year earlier. This is the relevant leverage measure for an insurer because policy and investment liabilities are integral to funding its operations, but it makes the value and income performance of the investment portfolio important.

The insurance backdrop includes changing bond yields and currency movements, which can affect bond valuations, reinvestment income, foreign-currency reinsurance and claims costs. The company reported LKR 70.2 billion of financial investments on 10 November, making those market variables material to reported earnings and capital.

Outlook

As at 11 November 2026, the next scheduled disclosure is the audited year to 31 December 2026, expected between 28 April and 3 June 2027. It will show whether nine-month premium growth and the reported LKR 602.3 million profit after tax carried through the year-end, or whether the weak September standalone margin marked a broader earnings slowdown.

The data cannot isolate how much future profit will come from underwriting, investment income or the general-insurance subsidiary. Bond-yield and currency changes remain relevant context for the insurer's investment and reinsurance exposures, but no company-specific financial effect has been quantified.

About this report. Generated on Nov 11, 2026 from market data up to Nov 11, 2026, 2 material news articles over 90 days and financials to Sep 30, 2026, and scored 74 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports